Tumor matrix protein collagen XIα1 in cancer

Cancer Letters

Volumn 357, Issue 2, 2015, Pages 448-453

  Raglow, Zoe ^a   Thomas, Sufi M ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; COL11A1; Collagen; ColXI 1; Extracellular matrix

Indexed keywords

APC PROTEIN; BETA CATENIN; BEVACIZUMAB; COLLAGEN TYPE 11; COLLAGEN TYPE 11 ALPHA1; MATRIX PROTEIN; SONIC HEDGEHOG PROTEIN; STROMELYSIN; TRANSCRIPTION FACTOR GLI1; TRANSFORMING GROWTH FACTOR BETA; TUMOR MARKER; TUMOR PROTEIN; UNCLASSIFIED DRUG;

BREAST CARCINOMA; CANCER RESISTANCE; COLORECTAL CARCINOMA; DISEASE ASSOCIATION; EPITHELIAL MESENCHYMAL TRANSITION; ESOPHAGUS CANCER; FIBROBLAST; GENE EXPRESSION; GENETIC ASSOCIATION; HEAD AND NECK CANCER; METASTASIS; MICROARRAY ANALYSIS; MOLECULARLY TARGETED THERAPY; NEOPLASM; NON SMALL CELL LUNG CANCER; OVARY CARCINOMA; PANCREAS CANCER; PAPILLARY CARCINOMA; PROTEIN EXPRESSION; PROTEIN FUNCTION; SHORT SURVEY; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SQUAMOUS CELL CARCINOMA; THYROID CARCINOMA; TUMOR ASSOCIATED FIBROBLAST; TUMOR BLOOD FLOW; TUMOR GROWTH; TUMOR INVASION; CANCER STAGING; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PATHOLOGY;

COLLAGEN TYPE XI; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM METASTASIS; NEOPLASM STAGING; NEOPLASMS;

EID: 84920853031     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2014.12.011     Document Type: Review

References (55)

1. Barkan D., Green J.E., Chambers A.F. Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth. Eur. J. Cancer 2010, 46:1181-1188.
2. Hynes R.O. The extracellular matrix: not just pretty fibrils. Science 2009, 326:1216-1219.
3. Levental K.R., Yu H., Kass L., et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 2009, 139:891-906.
4. Lo C.M., Wang H.B., Dembo M., et al. Cell movement is guided by the rigidity of the substrate. Biophys. J. 2000, 79:144-152.
5. Paszek M.J., Zahir N., Johnson K.R., et al. Tensional homeostasis and the malignant phenotype. Cancer Cell 2005, 8:241-254.
6. Quante M., Tu S.P., Tomita H., et al. Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth. Cancer Cell 2011, 19:257-272.
7. Orimo A., Gupta P.B., Sgroi D.C., et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005, 121:335-348.
8. Carter E.M., Raggio C.L. Genetic and orthopedic aspects of collagen disorders. Curr. Opin. Pediatr 2009, 21:46-54.
9. Grassel S., Bauer R.J. Collagen XVI in health and disease. Matrix Biol 2013, 32:64-73.
10. Ricard-Blum S. The collagen family. Cold Spring Harb. Perspect. Biol 2011, 3:a004978.
11. Yoshioka H., Iyama K., Inoguchi K., et al. Developmental pattern of expression of the mouse alpha 1 (XI) collagen gene (Col11a1). Dev. Dyn 1995, 204:41-47.
12. Hida M., Hamanaka R., Okamoto O., et al. Nuclear factor Y (NF-Y) regulates the proximal promoter activity of the mouse collagen alpha1(XI) gene (Col11a1) in chondrocytes. In Vitro Cell. Dev. Biol. Anim 2014, 50:358-366.
13. Domet M.J. The general pediatrician and the craniofacial defects team. Ear Nose Throat J. 1986, 65:296-304.
14. Vijzelaar R., Waller S., Errami A., et al. Deletions within COL11A1 in Type 2 stickler syndrome detected by multiplex ligation-dependent probe amplification (MLPA). BMC Med. Genet 2013, 14:48.
15. Bekdache G.N., Begam M.A., Chedid F., et al. Fibrochondrogenesis: prenatal diagnosis and outcome. J. Obstet. Gynaecol 2013, 33:663-668.
16. Rodriguez-Fontenla C., Calaza M., Evangelou E., et al. Assessment of osteoarthritis candidate genes in a meta-analysis of nine genome-wide association studies. Arthritis Rheumatol 2014, 66:940-949.
17. Mio F., Chiba K., Hirose Y., et al. A functional polymorphism in COL11A1, which encodes the alpha 1 chain of type XI collagen, is associated with susceptibility to lumbar disc herniation. Am. J. Hum. Genet 2007, 81:1271-1277.
18. Koyama K., Nakazato K., Min S., et al. COL11A1 gene is associated with limbus vertebra in gymnasts. Int. J. Sports Med 2012, 33:586-590.
19. Hay M., Patricios J., Collins R., et al. Association of type XI collagen genes with chronic Achilles tendinopathy in independent populations from South Africa and Australia. Br. J. Sports Med 2013, 47:569-574.
20. Fischer H., Stenling R., Rubio C., et al. Colorectal carcinogenesis is associated with stromal expression of COL11A1 and COL5A2. Carcinogenesis 2001, 22:875-878.
21. Fischer H., Salahshor S., Stenling R., et al. COL11A1 in FAP polyps and in sporadic colorectal tumors. BMC Cancer 2001, 1:17.
22. Imamura Y., Scott I.C., Greenspan D.S. The pro-alpha3(V) collagen chain. Complete primary structure, expression domains in adult and developing tissues, and comparison to the structures and expression domains of the other types V and XI procollagen chains. J. Biol. Chem 2000, 275:8749-8759.
23. Kim H., Watkinson J., Varadan V., et al. Multi-cancer computational analysis reveals invasion-associated variant of desmoplastic reaction involving INHBA, THBS2 and COL11A1. BMC Med Genomics 2010, 3:51.
24. Anastassiou D., Rumjantseva V., Cheng W., et al. Human cancer cells express Slug-based epithelial-mesenchymal transition gene expression signature obtained in vivo. BMC Cancer 2011, 11:529.
25. Chernov A.V., Baranovskaya S., Golubkov V.S., et al. Microarray-based transcriptional and epigenetic profiling of matrix metalloproteinases, collagens, and related genes in cancer. J. Biol. Chem 2010, 285:19647-19659.
26. An J.H., Lee S.Y., Jeon J.Y., et al. Identification of gliotropic factors that induce human stem cell migration to malignant tumor. J. Proteome Res 2009, 8:2873-2881.
27. Suceveanu A.I., Suceveanu A., Voinea F., et al. Introduction of cytogenetic tests in colorectal cancer screening. J. Gastrointestin. Liver Dis 2009, 18:33-38.
28. Wu Y.H., Chang T.H., Huang Y.F., et al. COL11A1 promotes tumor progression and predicts poor clinical outcome in ovarian cancer. Oncogene 2014, 33:3432-3440.
29. Teng P.N., Wang G., Hood B.L., et al. Identification of candidate circulating cisplatin-resistant biomarkers from epithelial ovarian carcinoma cell secretomes. Br. J. Cancer 2014, 110:123-132.
30. Cheon D.J., Tong Y., Sim M.S., et al. A collagen-remodeling gene signature regulated by TGF-beta signaling is associated with metastasis and poor survival in serous ovarian cancer. Clin. Cancer Res 2014, 20:711-723.
31. Tothill R.W., Tinker A.V., George J., et al. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Clin. Cancer Res 2008, 14:5198-5208.
32. Buckanovich R.J., Sasaroli D., O'Brien-Jenkins A., et al. Tumor vascular proteins as biomarkers in ovarian cancer. J. Clin. Oncol 2007, 25:852-861.
33. Vargas A.C., McCart Reed A.E., Waddell N., et al. Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression. Breast Cancer Res. Treat 2012, 135:153-165.
34. Castellana B., Escuin D., Peiro G., et al. ASPN and GJB2 are implicated in the mechanisms of invasion of ductal breast carcinomas. J Cancer 2012, 3:175-183.
35. Knudsen E.S., Ertel A., Davicioni E., et al. Progression of ductal carcinoma in situ to invasive breast cancer is associated with gene expression programs of EMT and myoepithelia. Breast Cancer Res. Treat 2012, 133:1009-1024.
36. Feng Y., Sun B., Li X., et al. Differentially expressed genes between primary cancer and paired lymph node metastases predict clinical outcome of node-positive breast cancer patients. Breast Cancer Res. Treat 2007, 103:319-329.
37. Ellsworth R.E., Seebach J., Field L.A., et al. A gene expression signature that defines breast cancer metastases. Clin. Exp. Metastasis 2009, 26:205-213.
38. Halsted K.C., Bowen K.B., Bond L., et al. Collagen alpha1(XI) in normal and malignant breast tissue. Mod. Pathol 2008, 21:1246-1254.
39. Sok J.C., Kuriakose M.A., Mahajan V.B., et al. Tissue-specific gene expression of head and neck squamous cell carcinoma in vivo by complementary DNA microarray analysis. Arch. Otolaryngol. Head Neck Surg 2003, 129:760-770.
40. Sok J.C., Lee J.A., Dasari S., et al. Collagen type XI alpha1 facilitates head and neck squamous cell cancer growth and invasion. Br. J. Cancer 2013, 109:3049-3056.
41. Schmalbach C.E., Chepeha D.B., Giordano T.J., et al. Molecular profiling and the identification of genes associated with metastatic oral cavity/pharynx squamous cell carcinoma. Arch. Otolaryngol. Head Neck Surg 2004, 130:295-302.
42. Chattopadhyay I., Singh A., Phukan R., et al. Genome-wide analysis of chromosomal alterations in patients with esophageal squamous cell carcinoma exposed to tobacco and betel quid from high-risk area in India. Mutat. Res 2010, 696:130-138.
43. Park H.J., Choe B.K., Kim S.K., et al. Association between collagen type XI alpha1 gene polymorphisms and papillary thyroid cancer in a Korean population. Exp. Ther. Med 2011, 2:1111-1116.
44. Chong I.W., Chang M.Y., Chang H.C., et al. Great potential of a panel of multiple hMTH1, SPD, ITGA11 and COL11A1 markers for diagnosis of patients with non-small cell lung cancer. Oncol. Rep 2006, 16:981-988.
45. Ewald J.A., Downs T.M., Cetnar J.P., et al. Expression microarray meta-analysis identifies genes associated with Ras/MAPK and related pathways in progression of muscle-invasive bladder transition cell carcinoma. PLoS ONE 2013, 8:e55414.
46. Zhao Y., Zhou T., Li A., et al. A potential role of collagens expression in distinguishing between premalignant and malignant lesions in stomach. Anat. Rec. (Hoboken) 2009, 292:692-700.
47. García Pravia C.F.M.N., García Ocaña M., Del Amo J., De los Toyos J.R., et al. Anti-proCOL11A1, a new marker of infiltrating breast cancer. Br. J. Surg 2009, S5:11.
48. Aquino P.F., Fischer J.S., Neves-Ferreira A.G., et al. Are gastric cancer resection margin proteomic profiles more similar to those from controls or tumors?. J. Proteome Res 2012, 11:5836-5842.
49. Garcia-Pravia C., Galvan J.A., Gutierrez-Corral N., et al. Overexpression of COL11A1 by cancer-associated fibroblasts: clinical relevance of a stromal marker in pancreatic cancer. PLoS ONE 2013, 8:e78327.
50. Fuentes-Martinez N., Garcia-Pravia C., Garcia-Ocana M., et al. Overexpression of proCOL11A1 as a stromal marker of breast cancer. Histol. Histopathol 2014.
51. Feldmann G., Habbe N., Dhara S., et al. Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer. Gut 2008, 57:1420-1430.
52. Gaspar N.J., Li L., Kapoun A.M., et al. Inhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness. Mol. Pharmacol 2007, 72:152-161.
53. Tuckwell D.S., Reid K.B., Barnes M.J., et al. The A-domain of integrin alpha 2 binds specifically to a range of collagens but is not a general receptor for the collagenous motif. Eur. J. Biochem 1996, 241:732-739.
54. Shrivastava A., Radziejewski C., Campbell E., et al. An orphan receptor tyrosine kinase family whose members serve as nonintegrin collagen receptors. Mol. Cell 1997, 1:25-34.
55. Brown R.J., Mallory C., McDougal O.M., et al. Proteomic analysis of Col11a1-associated protein complexes. Proteomics 2011, 11:4660-4676.